SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Summit Technology (BEAM) -- Ignore unavailable to you. Want to Upgrade?


To: lastbear who wrote (801)3/27/1998 4:17:00 PM
From: Manny Gugliuzza  Respond to of 1386
 
ok but they put 1.25 on the lvc p/s when distributed for tax purposes
and because that's what the market beared. lcav paid 10 mil + stock 17X 1.25 divided by 36.6= .854 cents per share. so trading at 2x book very tolerable yes, for lcav anyway.

summit owns 20% of this so that is a little more than .50 cents per share of summit. and they are selling at nearly 2x book also so much room for expansion no?

what are those figures for lens crafters pappy? let us grind this out.

thanks

ar.



To: lastbear who wrote (801)3/27/1998 7:55:00 PM
From: Manny Gugliuzza  Read Replies (1) | Respond to of 1386
 
i think the cash is higher near 2.5 or 3and lens expeven at 50 mil is div by 22 mil sh =2.3 lcav 14 mil div by 22=.60 so that is about 6 at 2x book =12 easy double

ar.